Day One Biopharmaceuticals, Inc. (DAWN)

NMS – Цена в реальном времени. Валюта: USD

21.53

+21.53 (0.00%)

При закрытии: Apr 22, 2026, 4:00 PM EDT

23.04.2026

Servier completes the acquisition of Day One Biopharmaceuticals

Acquisition expands Servier's position in oncology with tovorafenib marketed as OJEMDATM in the U.S . in pediatric low-grade glioma.

26.03.2026

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Day One Biopharmaceuticals, Inc. (NasdaqGS: DAWN) to Servier. Under the terms of the proposed transaction, shareholders of Day One will receive $21.50 in cash for each share of Day One that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate,.

09.03.2026

Are DAWN and TALK Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers.

09.03.2026

DAWN Stock Jumps 66% on $2.5B Buyout Offer From Servier

Day One's stock surges 66% after Servier agrees to acquire it for $21.50 per share in a $2.5B deal, adding brain tumor drug Ojemda and oncology pipeline assets.

06.03.2026

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

06.03.2026

Stock Market Today, March 6: Energy Stocks Rise as Oil Closes Over $90 on Middle East Tensions

The S&P 500 (^GSPC 1.33%) fell 1.33% to 6,740.02, the Nasdaq Composite (^IXIC 1.59%) slid 1.59% to 22,387.68, and the Dow Jones Industrial Average (^DJI 0.95%) dropped 0.95% to 47,501.55 as a weak jobs report and surging oil reinforced risk-off sentiment.

06.03.2026

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Day One Biopharmaceuticals, Inc. (DAWN)

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - March 6, 2026) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Day One Biopharmaceuticals, Inc. ("Day One" or the "Company") (NASDAQ: DAWN) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Servier for $21.50 per share in an all-cash transaction, representing a total equity value of approximately $2.5 billion. The investigation concerns whether the Day One Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company's shareholders.

Видео

No Data

There is no data to display

Пресс-релизы

23.04.2026

Servier completes the acquisition of Day One Biopharmaceuticals

Acquisition expands Servier's position in oncology with tovorafenib marketed as OJEMDATM in the U.S . in pediatric low-grade glioma.

26.03.2026

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

09.03.2026

Are DAWN and TALK Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers.

06.03.2026

Day One Biopharmaceuticals, Inc. (DAWN)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Day One Biopharmaceuticals, Inc. (DAWN)

Servier completes the acquisition of Day One Biopharmaceuticals

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

Are DAWN and TALK Obtaining Fair Deals for their Shareholders?

DAWN Stock Jumps 66% on $2.5B Buyout Offer From Servier

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

Stock Market Today, March 6: Energy Stocks Rise as Oil Closes Over $90 on Middle East Tensions

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Day One Biopharmaceuticals, Inc. (DAWN)

Видео

No Data

Пресс-релизы

Servier completes the acquisition of Day One Biopharmaceuticals

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

Are DAWN and TALK Obtaining Fair Deals for their Shareholders?

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

Servier completes the acquisition of Day One Biopharmaceuticals

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

Are DAWN and TALK Obtaining Fair Deals for their Shareholders?

DAWN Stock Jumps 66% on $2.5B Buyout Offer From Servier

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

Stock Market Today, March 6: Energy Stocks Rise as Oil Closes Over $90 on Middle East Tensions

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Day One Biopharmaceuticals, Inc. (DAWN)

Видео

No Data

Пресс-релизы

Servier completes the acquisition of Day One Biopharmaceuticals

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

Are DAWN and TALK Obtaining Fair Deals for their Shareholders?

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

Search stocks

Day One Biopharmaceuticals, Inc. (DAWN)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Day One Biopharmaceuticals, Inc. (DAWN)

Servier completes the acquisition of Day One Biopharmaceuticals

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

Are DAWN and TALK Obtaining Fair Deals for their Shareholders?

DAWN Stock Jumps 66% on $2.5B Buyout Offer From Servier

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

Stock Market Today, March 6: Energy Stocks Rise as Oil Closes Over $90 on Middle East Tensions

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Day One Biopharmaceuticals, Inc. (DAWN)

Видео

No Data

Пресс-релизы

Servier completes the acquisition of Day One Biopharmaceuticals

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

Are DAWN and TALK Obtaining Fair Deals for their Shareholders?

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

Servier completes the acquisition of Day One Biopharmaceuticals

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

Are DAWN and TALK Obtaining Fair Deals for their Shareholders?

DAWN Stock Jumps 66% on $2.5B Buyout Offer From Servier

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

Stock Market Today, March 6: Energy Stocks Rise as Oil Closes Over $90 on Middle East Tensions

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Day One Biopharmaceuticals, Inc. (DAWN)

Видео

No Data

Пресс-релизы

Servier completes the acquisition of Day One Biopharmaceuticals

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

Are DAWN and TALK Obtaining Fair Deals for their Shareholders?

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN